These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1544 related articles for article (PubMed ID: 26895526)

  • 21. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
    Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
    Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: The Role of Vertebral Endplate Disruption.
    Dibs K; Facer B; Mageswaran P; Raval R; Thomas E; Gogineni E; Beyer S; Pan J; Klamer B; Ayan A; Bourekas E; Boulter D; Fetko N; Cochran E; Zoller I; Chakravarthy V; Tili E; Elder JB; Lonser R; Elguindy A; Soghrati S; Marras W; Grecula J; Chakravarti A; Palmer J; Blakaj DM
    Neurosurgery; 2024 Apr; 94(4):797-804. PubMed ID: 37902322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity.
    Ling DC; Flickinger JC; Burton SA; Heron DE; Quinn AE; Bejjani GK; Engh JA; Gerszten PC; Amankulor NM; Vargo JA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):602-609. PubMed ID: 29678526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
    Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
    Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases.
    Ozdemir Y; Torun N; Guler OC; Yildirim BA; Besen AA; Yetisken AG; Onal HC; Topkan E
    J Bone Oncol; 2019 Apr; 15():100218. PubMed ID: 30815342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K
    J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-irradiation spine stereotactic body radiotherapy following high-dose conventional radiotherapy for metastatic epidural spinal cord compression: a retrospective study.
    Koide Y; Haimoto S; Shimizu H; Aoyama T; Kitagawa T; Shindo Y; Nagai N; Hashimoto S; Tachibana H; Kodaira T
    Jpn J Radiol; 2024 Jun; 42(6):662-672. PubMed ID: 38413551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
    Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk for surgical complications after previous stereotactic body radiotherapy of the spine.
    Roesch J; Cho JBC; Fahim DK; Gerszten PC; Flickinger JC; Grills IS; Jawad M; Kersh R; Letourneau D; Mantel F; Sahgal A; Shin JH; Winey B; Guckenberger M
    Radiat Oncol; 2017 Sep; 12(1):153. PubMed ID: 28893299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases.
    Sahgal A; Whyne CM; Ma L; Larson DA; Fehlings MG
    Lancet Oncol; 2013 Jul; 14(8):e310-20. PubMed ID: 23816297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases.
    Koyfman SA; Djemil T; Burdick MJ; Woody N; Balagamwala EH; Reddy CA; Angelov L; Suh JH; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):297-302. PubMed ID: 21985940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological characteristics of spine metastases treated with high-dose single-fraction stereotactic radiosurgery.
    Katsoulakis E; Laufer I; Bilsky M; Agaram NP; Lovelock M; Yamada Y
    Neurosurg Focus; 2017 Jan; 42(1):E7. PubMed ID: 28041326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
    Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
    Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
    Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A
    J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of vertebral compression fracture specific to osteolytic renal cell carcinoma spinal metastases after stereotactic body radiotherapy: A multi-institutional study.
    Thibault I; Atenafu EG; Chang E; Chao S; Ameen AO; Zhou S; Boehling N; Balagamwala EH; Cunha M; Cho J; Angelov L; Brown PD; Suh J; Rhines LD; Fehlings MG; Sahgal A
    J Radiosurg SBRT; 2015; 3(4):297-305. PubMed ID: 29296412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
    Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.